Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Lilly Abemaciclib Research Grant Opportunity: Submit by Friday, July 10, 2020
Study Proposal Submission-NCCN iEnvision
NCCN Pfizer Axitinib Research Grant Opportunity: Submit by Wednesday, August 12, 2020
NCCN Pfizer Biosimilars Grant Opportunity - Submit by Wednesday, September 9, 2020
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Policy Priorities

NCCN Research & Business Resources

Find a clinical trial >


The Case Comprehensive Cancer Center (Case CCC) based at Case Western Reserve University (CWRU) is a partnership organization supporting cancer-related research efforts at CWRU, University Hospitals Seidman Cancer Center at Case Medical Center, and Cleveland Clinic. Located in Cleveland, Ohio, the Case CCC is situated in an urban manufacturing and rural agricultural region containing 3.8 million people in Northern Ohio.

The Case CCC provides a unique forum and academic network for cancer researchers to accomplish more than they may individually. Through the Case CCC, our medical institutions are linked in a stronger and more unified effort to understand the causes and progression of cancer and to use that understanding to develop cancer and suffer from its consequences. The Cancer Center advocates for cancer research support across the institutions; provides funding for promising pilot grants, shared resource development, training programs, and recruitments; and catalyzes multidisciplinary and transdisciplinary cancer research, emphasizing innovative discovery that will have an impact on cancer patients.

The mission of the Case CCC is to:

  • Improve the prevention, diagnosis and therapy of cancer through discovery, evaluation and dissemination.
  • Stimulate and support innovative, coordinated interdisciplinary clinical research on cancer diagnosis, treatment, prevention and control.
  • Develop clinical applications of discovery and make these available as quickly as possible through the integrated efforts of the major health systems in the region.
  • Develop cancer prevention and control activities that build on the expertise of the Center and result in a reduction of cancer morbidity and mortality in Northern Ohio and the nation.

The research efforts of the Case CCC members are organized into eight interdisciplinary scientific programs. The clinical research effort is supported by 11 Clinical Trials Disease Teams that develop and prioritize clinical trials, and a single Protocol Review and Monitoring System, Data Safety and Monitoring Plan integrate cancer research, cancer therapeutics, and prevention services at the partner institutions and throughout the region. Research programs of the Case CCC are also extending into community medical centers operated by University Hospitals Seidman Cancer Center and Cleveland Clinic. Outreach programs for clinical practice-based prevention and screening initiatives, educational programs, minority recruitment, and facilitation of patient referrals are also supported by the partner institutions.

University Hospitals Seidman Cancer Center

Located on the main campus of University Hospitals Case Medical Center in Cleveland, Ohio, UH Seidman Cancer Center opened in spring 2011. The 375,000-square-foot hospital houses all of our cancer services under one roof to optimize patient- and family-centered care, provide the latest therapies, enhance collaboration and promote clinical research and education.

UH Seidman Cancer Center is named in honor of Jane and Lee Seidman, who generously donated $42 million in support of Vision 2010: The UH Difference strategic initiative. Patients and families at UH Seidman Cancer Center have access to exceptional care from a team of nurses, doctors, support personnel and many others. A collaborative group of specialists provides input on each patient’s case. This multidisciplinary team formulates one single consistent plan, resulting in more effective and efficient care.

UH Seidman Cancer Center is home to the latest treatment protocols and the most advanced diagnostic, therapeutic and information technologies. Among them are the PET/MRI machine, a hybrid scanner that helps physicians better understand disease development. Our cancer center is the first U.S. cancer hospital to have this technology. Other advanced technology at UH Seidman Cancer Center includes:

  • CyberKnife®
  • Gamma Knife® radiosurgery
  • Image-guided linear accelerator technology
  • Intraoperative radiation therapy
  • Tomotherapy

The physician-scientists at UH Seidman Cancer Center are also dedicated to clinical research to develop and test the most innovative treatment options and enhance patient care. NHI-funded research at UH is awarded through Case Western Reserve University. We also offer patients the option of participating in a clinical trial. Hundreds of clinical trials are available to our patients, giving them access to the latest medications and treatment options, and increasing their odds in the fight against cancer.

Cleveland Clinical Taussig Cancer Institute

Cleveland Clinic Taussig Cancer Institute is committed to providing patients with superior cancer care in a cooperative, compassionate and innovative practice. As the hub of cancer services at Cleveland Clinic, Taussig Cancer Institute staff collaborate and coordinate care with other cancer specialists throughout Cleveland Clinic. The result is highly experienced, impeccable clinical care, robust cancer research, extensive support services and better access to care for patients with cancer and their families.  Multidisciplinary teams at Taussig include clinicians who specialize in medical and radiation oncology, bone marrow transplantation, palliative care, oncology nursing, cancer research and psychosocial support. Working in close collaboration with other cancer specialists at Cleveland Clinic such as surgical oncologists, plastic surgeons, gastroenterologists, interventional radiologists, pathologists and genetic counselors, Taussig clinicians offer patients the most advanced clinical care tailored to their individual needs.

Cancer research provides patients with the latest diagnostic and treatment options available. An extensive clinical trials research program provides patients access to the newest drugs and techniques in cancer care. Internationally recognized translational research efforts bring new discoveries about cancer from the laboratory to patients. Other specialized cancer resources at Cleveland Clinic such as genomics and molecular pathology illuminate the genetic and molecular characteristics of cancer to inform effective treatment.

Taussig Cancer Institute offers patients and families a growing range of support programs and survivorship services to enhance quality of life and provide support in coping with the challenges of cancer and its treatment.  Convenient access to physicians, medical and radiation oncology treatment, clinical trials and support services is available throughout northern Ohio at several Taussig Cancer Institute community locations.